| scholarly article | Q13442814 |
| P50 | author | Alex Dickens | Q83327542 |
| Michelle M Mielke | Q60909929 | ||
| P2093 | author name string | Gretchen E Tietjen | |
| Joelle M Dorskind | |||
| Veera Venkata Ratnam Bandaru | |||
| B Lee Peterlin | |||
| Subroto Chatterjee | |||
| Paul Dash | |||
| Guillermo Alexander | |||
| Norman H Haughey | |||
| Rebeca V A Vieira | |||
| P2860 | cites work | Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells | Q64381769 |
| Lipid composition of platelets in patients suffering from migraine without aura | Q71475248 | ||
| Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro | Q74405469 | ||
| Sphingolipids in atherosclerosis and vascular biology | Q77380912 | ||
| Pathophysiology of migraine | Q83481488 | ||
| Ceramide metabolism is affected by obesity and diabetes in human adipose tissue | Q83711035 | ||
| The PHQ-9: validity of a brief depression severity measure | Q24550620 | ||
| A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis | Q24644684 | ||
| On ceramides, other sphingolipids and impaired glucose homeostasis | Q27021446 | ||
| Central leptin regulates total ceramide content and sterol regulatory element binding protein-1C proteolytic maturation in rat white adipose tissue | Q28571941 | ||
| The International Classification of Headache Disorders: 2nd edition | Q29547231 | ||
| The role of neurogenetics in Gaucher disease | Q33492930 | ||
| Lactosylceramide recruits PKCalpha/epsilon and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells | Q33695206 | ||
| Migraine and stroke: a complex association with clinical implications | Q34240928 | ||
| What do patients want from acute migraine treatment? | Q34375878 | ||
| Pathophysiology of migraine | Q34494322 | ||
| Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study | Q34777915 | ||
| Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. | Q35101294 | ||
| C16:0-ceramide signals insulin resistance | Q35362267 | ||
| Ceramides as modulators of cellular and whole-body metabolism | Q35484864 | ||
| Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. | Q36149981 | ||
| Lipid mediators of sensitivity in sensory neurons | Q36268577 | ||
| Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial | Q36696303 | ||
| Episodic migraine and obesity and the influence of age, race, and sex | Q37251663 | ||
| Sphingolipids in inflammation: pathological implications and potential therapeutic targets. | Q37447464 | ||
| A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects | Q37463446 | ||
| Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate | Q37515719 | ||
| Ceramide and ceramide 1-phosphate in health and disease. | Q37688315 | ||
| Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity | Q37930550 | ||
| A world of sphingolipids and glycolipids in the brain--novel functions of simple lipids modified with glucose | Q38002318 | ||
| Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. | Q38073981 | ||
| Lipid rafts control P2X3 receptor distribution and function in trigeminal sensory neurons of a transgenic migraine mouse model | Q38711699 | ||
| Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients | Q41528498 | ||
| Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia | Q44750872 | ||
| Caspase signalling in neuropathic and inflammatory pain in the rat. | Q45173036 | ||
| Insulin sensitivity is impaired in patients with migraine | Q46610301 | ||
| Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance | Q47431942 | ||
| Increased serum levels of adiponectin in migraine. | Q47876962 | ||
| Oligomerization state-dependent elevations of adiponectin in chronic daily headache. | Q51702634 | ||
| A six-item short-form survey for measuring headache impact: the HIT-6. | Q53363511 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| sphingolipids | Q410395 | ||
| P304 | page(s) | 1214-1223 | |
| P577 | publication date | 2015-09-09 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Interictal, circulating sphingolipids in women with episodic migraine: A case-control study | |
| P478 | volume | 85 |
| Q37415284 | A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria |
| Q93379549 | Ceramides as Novel Disease Biomarkers |
| Q86101381 | Comment: Altered sphingolipid metabolism--A marker for episodic migraine? |
| Q97645600 | Pharmacokinetic and Lipidomic Assessment of the In Vivo Effects of Parishin A-Isorhynchophylline in Rat Migraine Models |
| Q92871125 | Sex-specific perturbation of complex lipids in response to medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency |
| Q104064258 | Sphingomyelin is involved in multisite musculoskeletal pain: evidence from metabolomic analysis in two independent cohorts |
| Q95942926 | The impact of Dl-3-n-butylphthalide on the lipidomics of the hippocampus in a rat model of lipopolysaccharide-induced depression |
| Q90318251 | The role of dihydrosphingolipids in disease |
Search more.